Company Profile

Precipio Diagnostics Stock Price, News & Analysis

Ticker:
PRPO
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Precipio Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Stock performance

23.20 USD (-0.19%)

Close

Last updated: June 23, 2026 at 00:00

41.47M USD

Market cap

Why the stock is moving

PRPO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Precipio Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Precipio Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles.

Business Model Characteristics

Precipio Diagnostics is a commercial-tools story where install base, recurring demand, and product adoption drive the narrative more than one-off clinical events.

Position Within the Biotechnology Landscape

Compared with therapeutic biotech names, Precipio Diagnostics sits on a different part of the landscape where utilization, customer demand, and product refresh tend to matter more than binary FDA events.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Precipio Diagnostics (PRPO)?

    Precipio Diagnostics (PRPO) most recently closed at 23.20 USD, a -0.19% move versus the previous session.

    What is the market cap of Precipio Diagnostics (PRPO)?

    Precipio Diagnostics currently has a market capitalization of 41.47M USD on BioPharmSignal.

    What does Precipio Diagnostics do?

    Precipio Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    On which exchange is PRPO stock listed?

    Precipio Diagnostics (PRPO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Precipio Diagnostics is followed within the diagnostics and tools universe for its exposure to customer demand and adoption cycles., Biotechnology.

    What is Precipio?

    Precipio Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    Which conditions is Precipio Diagnostics targeting with Precipio?

    Precipio Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.

    What is Diagnostics?

    Precipio Diagnostics is a diagnostics and life sciences tools company focused on testing, assay adoption, and workflow utility, with investors watching recurring demand and product mix as much as clinical news flow.